non-clinical safety evaluation of camelina oil: acute and 12-week oral toxicities

This study assessed the acute and sub-chronic toxicity of camelina oil, a well-known oil rich in polyunsaturated fatty acids that enhance cellular immunity and human health, in wistar rats. wistar rats, 5 per sex per group, were randomly assigned to three groups for acute (14 days) toxicity studies and five groups for sub-chronic (90 days) toxicity studies. in the acute study, camelina sativa oil was administered orally at a single dose of 5000 mg/kg of body weight (bw). the positive control group received a single dose of 5 000 mg/kg bw canola oil by gavage. in the sub-chronic study, groups iii-v received 250, 500, and 1 000 mg/kg bw of camelina oil, while groups i and ii received ultra-pure water and canola oil at a dose of 500 mg/kg bw, respectively. throughout the experiment, clinical signs, mortality, and body weight were monitored. at the end of the sub-chronic study, hematological, biochemical, and histopathological investigations were conducted. administration of camelina oil and canola had no significant effect on daily weight gain (p > 0.05) of the test rats. serum calcium levels decreased while phosphorous levels increased in male rats treated with camelina oil. other hematological and biochemical parameters showed no significant differences or dose-response effects between control and seed oil groups in both sexes (p < 0.05). moreover, in animal necropsy, there were no apparent lesions in the liver, heart, and kidney organs in any of the doses administered. in conclusion, the results suggest that oral administration of camelina oil is unlikely to be toxic. therefore, the possibility for the development of future human nutrition should be considered.